Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: Q4Q7F5
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 5 |
GO:0006259 | DNA metabolic process | 4 | 5 |
GO:0006308 | DNA catabolic process | 5 | 5 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 5 |
GO:0006807 | nitrogen compound metabolic process | 2 | 5 |
GO:0008152 | metabolic process | 1 | 5 |
GO:0009056 | catabolic process | 2 | 5 |
GO:0009057 | macromolecule catabolic process | 4 | 5 |
GO:0009987 | cellular process | 1 | 5 |
GO:0019439 | aromatic compound catabolic process | 4 | 5 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 5 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 5 |
GO:0043170 | macromolecule metabolic process | 3 | 5 |
GO:0044237 | cellular metabolic process | 2 | 5 |
GO:0044238 | primary metabolic process | 2 | 5 |
GO:0044248 | cellular catabolic process | 3 | 5 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 5 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 5 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 5 |
GO:0046483 | heterocycle metabolic process | 3 | 5 |
GO:0046700 | heterocycle catabolic process | 4 | 5 |
GO:0071704 | organic substance metabolic process | 2 | 5 |
GO:0090304 | nucleic acid metabolic process | 4 | 5 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 5 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 5 |
GO:1901575 | organic substance catabolic process | 3 | 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 5 |
GO:0003824 | catalytic activity | 1 | 5 |
GO:0004518 | nuclease activity | 4 | 5 |
GO:0004519 | endonuclease activity | 5 | 5 |
GO:0005488 | binding | 1 | 5 |
GO:0016787 | hydrolase activity | 2 | 5 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 5 |
GO:0043167 | ion binding | 2 | 5 |
GO:0043169 | cation binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
GO:0097159 | organic cyclic compound binding | 2 | 5 |
GO:1901363 | heterocyclic compound binding | 2 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 109 | 113 | PF00656 | 0.675 |
CLV_PCSK_FUR_1 | 117 | 121 | PF00082 | 0.483 |
CLV_PCSK_FUR_1 | 158 | 162 | PF00082 | 0.622 |
CLV_PCSK_KEX2_1 | 119 | 121 | PF00082 | 0.376 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.558 |
CLV_PCSK_PC1ET2_1 | 119 | 121 | PF00082 | 0.376 |
CLV_PCSK_PC1ET2_1 | 160 | 162 | PF00082 | 0.558 |
CLV_PCSK_SKI1_1 | 57 | 61 | PF00082 | 0.596 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.661 |
DEG_SCF_FBW7_1 | 102 | 109 | PF00400 | 0.675 |
DOC_AGCK_PIF_2 | 42 | 47 | PF00069 | 0.583 |
DOC_PP2B_PxIxI_1 | 20 | 26 | PF00149 | 0.320 |
DOC_PP4_FxxP_1 | 13 | 16 | PF00568 | 0.320 |
DOC_WW_Pin1_4 | 102 | 107 | PF00397 | 0.683 |
DOC_WW_Pin1_4 | 12 | 17 | PF00397 | 0.336 |
LIG_14-3-3_CanoR_1 | 125 | 129 | PF00244 | 0.558 |
LIG_14-3-3_CterR_2 | 158 | 163 | PF00244 | 0.828 |
LIG_APCC_ABBA_1 | 86 | 91 | PF00400 | 0.683 |
LIG_BRCT_BRCA1_1 | 91 | 95 | PF00533 | 0.683 |
LIG_eIF4E_1 | 131 | 137 | PF01652 | 0.683 |
LIG_FHA_2 | 107 | 113 | PF00498 | 0.675 |
LIG_FHA_2 | 72 | 78 | PF00498 | 0.683 |
LIG_FHA_2 | 79 | 85 | PF00498 | 0.595 |
LIG_LIR_Apic_2 | 15 | 21 | PF02991 | 0.320 |
LIG_LIR_Apic_2 | 71 | 76 | PF02991 | 0.683 |
LIG_LIR_Gen_1 | 43 | 50 | PF02991 | 0.583 |
LIG_LIR_Nem_3 | 17 | 23 | PF02991 | 0.386 |
LIG_LIR_Nem_3 | 34 | 40 | PF02991 | 0.339 |
LIG_LIR_Nem_3 | 43 | 48 | PF02991 | 0.466 |
LIG_LIR_Nem_3 | 99 | 104 | PF02991 | 0.683 |
LIG_LYPXL_S_1 | 19 | 23 | PF13949 | 0.320 |
LIG_LYPXL_yS_3 | 101 | 104 | PF13949 | 0.683 |
LIG_LYPXL_yS_3 | 20 | 23 | PF13949 | 0.320 |
LIG_NRBOX | 132 | 138 | PF00104 | 0.683 |
LIG_Pex14_2 | 38 | 42 | PF04695 | 0.583 |
LIG_Pex14_2 | 56 | 60 | PF04695 | 0.808 |
LIG_SH2_CRK | 26 | 30 | PF00017 | 0.341 |
LIG_SH2_CRK | 45 | 49 | PF00017 | 0.583 |
LIG_SH2_PTP2 | 28 | 31 | PF00017 | 0.510 |
LIG_SH2_SRC | 18 | 21 | PF00017 | 0.493 |
LIG_SH2_SRC | 28 | 31 | PF00017 | 0.447 |
LIG_SH2_STAT5 | 114 | 117 | PF00017 | 0.558 |
LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.671 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.397 |
LIG_SH2_STAT5 | 24 | 27 | PF00017 | 0.579 |
LIG_SH2_STAT5 | 28 | 31 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.370 |
LIG_SH2_STAT5 | 37 | 40 | PF00017 | 0.374 |
LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.625 |
LIG_SH3_3 | 139 | 145 | PF00018 | 0.769 |
LIG_SUMO_SIM_anti_2 | 81 | 87 | PF11976 | 0.683 |
LIG_SUMO_SIM_par_1 | 84 | 92 | PF11976 | 0.683 |
LIG_TYR_ITSM | 97 | 104 | PF00017 | 0.683 |
MOD_CK2_1 | 71 | 77 | PF00069 | 0.564 |
MOD_GlcNHglycan | 42 | 45 | PF01048 | 0.583 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.675 |
MOD_N-GLC_1 | 97 | 102 | PF02516 | 0.389 |
MOD_NEK2_1 | 69 | 74 | PF00069 | 0.556 |
MOD_PKA_2 | 124 | 130 | PF00069 | 0.558 |
MOD_Plk_1 | 147 | 153 | PF00069 | 0.773 |
MOD_Plk_1 | 89 | 95 | PF00069 | 0.683 |
MOD_Plk_1 | 97 | 103 | PF00069 | 0.583 |
MOD_Plk_2-3 | 147 | 153 | PF00069 | 0.773 |
MOD_Plk_2-3 | 71 | 77 | PF00069 | 0.683 |
MOD_Plk_4 | 14 | 20 | PF00069 | 0.459 |
MOD_ProDKin_1 | 102 | 108 | PF00069 | 0.683 |
MOD_ProDKin_1 | 12 | 18 | PF00069 | 0.336 |
TRG_DiLeu_BaLyEn_6 | 65 | 70 | PF01217 | 0.683 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.558 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.545 |
TRG_ENDOCYTIC_2 | 24 | 27 | PF00928 | 0.661 |
TRG_ENDOCYTIC_2 | 28 | 31 | PF00928 | 0.404 |
TRG_ENDOCYTIC_2 | 37 | 40 | PF00928 | 0.281 |
TRG_ENDOCYTIC_2 | 45 | 48 | PF00928 | 0.583 |
TRG_NES_CRM1_1 | 77 | 91 | PF08389 | 0.683 |
TRG_Pf-PMV_PEXEL_1 | 80 | 84 | PF00026 | 0.483 |